Charles Coverdale resumes & CV records
Resumes
Charles Coverdale
Location:
Kalamazoo, MI
Industry:
Chemicals
Charles E Coverdale, Age 891400 N Drake Rd UNIT 222, Kalamazoo, MI 49006
Charles Coverdale Phones & Addresses
Kalamazoo, MI
Arcadia, MI
St Pete Beach, FL
5138 Grosse Pointe St, Portage, MI 49024 (269) 345-9224
Social networks
Charles E Coverdale
Linkedin
Work
Position:
Production Occupations
Education
Degree:
High school graduate or higher
Emails
Industries
Chemicals
Mentions for Charles E Coverdale
Publications & IP owners
Wikipedia
Charles Harry Coverdale
Charles Harry Coverdale VC MM (21 April 1888 - 20 November 1955) was an English recipient of the Victoria Cross, the highest and most prestigious award for gallantry in the ...
Us Patents
Quinolylaminobenzoylpiperazine-1-Oxides
US Patent:
3992382, Nov 16, 1976
Filed:
Sep 23, 1974
Appl. No.:
5/508790
Inventors:
Charles E. Coverdale - Portage MI
Louis L. Skaletzky - Kalamazoo MI
Louis L. Skaletzky - Kalamazoo MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
C07D29516
US Classification:
260268BQ
Abstract:
Novel compounds of the formula: ##SPC1## Are disclosed with the corresponding hydrates and pharmaceutically acceptable acid addition salts thereof, wherein R. sub. 1 is halogen, lower alkyl, or trifluoromethyl; R. sub. 2 is lower alkyl, substituted or unsubstituted phenyl or benzyl and R. sub. 3 is hydrogen. The novel compounds are useful for the treatment of hypertension and anxiety in mammals, including humans. Disclosed also are compositions containing the novel compounds of the invention and methods of their use in the treatment of hypertension and anxiety.
Compositions And Method Of Using Quinolylaminobenzoylpiperazino-1-Oxides
US Patent:
4057633, Nov 8, 1977
Filed:
Aug 18, 1976
Appl. No.:
5/715229
Inventors:
Charles E. Coverdale - Portage MI
Louis L. Skaletzky - Kalamazoo MI
Louis L. Skaletzky - Kalamazoo MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
A61K 31495
US Classification:
424250
Abstract:
Novel compounds of the formula: ##STR1## are disclosed with the corresponding hydrates and pharamceutically acceptable acid addition salts thereof, wherein R. sub. 1 is halogen, lower alkyl, or trifluoromethyl; R. sub. 2 is lower alkyl, substituted or unsubstituted phenyl or benzyl and R. sub. 3 is hydrogen. The novel compounds are useful for the treatment of hypertension and anxiety in mammals, including humans. Disclosed also are compositions containing the novel compounds of the invention and methods of their use in the treatment of hypertension and anxiety.
P-(Trifluoromethylquinolylamino)Benzamides, Pharmaceutical Dosage Forms And Method Of Treatment
US Patent:
4025629, May 24, 1977
Filed:
Mar 21, 1975
Appl. No.:
5/560918
Inventors:
Charles E. Coverdale - Portage MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
A61K 3147
C07D21544
C07D21544
US Classification:
424250
Abstract:
Novel p-(trifluoromethylquinolylamino)benzamides are provided, for example, p-[(7-trifluoromethyl-4-quinolyl)-amino]-N,N-(3-methyl-3-azapentamethylene )benzamide and 1-[p-[[7-(trifluoromethyl)-4-quinolyl]amino]benzoyl]piperazine dihydrochloride. Also provided are pharmaceutical dosage unit forms for systemic administration and methods for their systemic administration. The compound, dosage unit forms and methods of systemic administration are useful in obtaining antihypertensive and anti-anxiety effects in mammals.
Compositions And Method For Treating Epilepsy And Convulsions
US Patent:
4004029, Jan 18, 1977
Filed:
Sep 8, 1975
Appl. No.:
5/610939
Inventors:
Robert James Collins - Portage MI
Charles E. Coverdale - Portage MI
Charles E. Coverdale - Portage MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
A61K 3113
US Classification:
424325
Abstract:
Compounds of the formula ##STR1## wherein R. sub. 1 and R. sub. 2 are each hydrogen or lower alkyl, R. sub. 3 represents lower alkyl and A is a monovalent group of formula: ##STR2## wherein Y is hydrogen or the acyl radical of a hydrocarbon carboxylic acid having from 2 to 18 carbon atoms, inclusive, are employed as anticonvulsants in treating mammals, including humans. Novel compounds within the scope of the above formula are also disclosed, wherein R. sub. 1 is specifically lower alkyl and provided that R. sub. 1 is located in a position ortho or meta to the substituent group A when R. sub. 2 is hydrogen. Disclosed also are novel intermediate compounds for preparing the above-described novel compounds of the invention, which correspond thereto but wherein the group A is replaced by a nitro-group.
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.